TCS 3,657.70 +26.15 (0.72%) 
HDFCBANK 1,821.45 +20.30 (1.13%) HINDUNILVR 2,270.70 +14.55 (0.64%) INFY 1,631.70 +39.50 (2.48%) HDFC 2,729.95 -17.05 (-0.62%) BHARTIARTL 1,733.70 +15.40 (0.90%) KOTAKBANK 2,170.85 -7.50 (-0.34%) ICICIBANK 1,344.40 -13.80 (-1.02%) ITC 409.90 -1.05 (-0.26%) BAJFINANCE 9,071.60 -23.30 (-0.26%) MARUTI 11,897.30 -25.55 (-0.21%) HCLTECH 1,626.25 +22.15 (1.38%) SBIN 773.05 -8.35 (-1.07%) NESTLEIND 2,255.55 -7.80 (-0.34%) ASIANPAINT 2,330.35 +8.35 (0.36%) WIPRO 271.10 +1.70 (0.63%) DMART 3,998.40 +95.40 (2.44%) AXISBANK 1,119.60 +21.60 (1.97%) LT 3,469.70 -11.40 (-0.33%) HDFCLIFE 673.50 -5.90 (-0.87%) SUNPHARMA 1,766.00 -19.30 (-1.08%) ULTRACEMCO 11,428.05 +377.25 (3.41%) ONGC 242.20 -1.55 (-0.64%) BAJAJFINSV 1,946.10 +51.30 (2.71%) BPCL 279.05 -1.40 (-0.50%) POWERGRID 291.15 -0.75 (-0.26%) TITAN 3,055.15 -23.80 (-0.77%) BRITANNIA 4,846.30 +49.55 (1.03%) NTPC 367.15 -0.20 (-0.05%) Download Unicorn Signals App
By EquityPandit
Glenmark Pharmaceuticals has got the US health regulator’s final approval for a generic version of anti-bacterial drug Zyvox.
The company said in a statement that “Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the US Food & Drug Administration (USFDA) for the Linezolid tablets, 600 mg.”
It further said that the product is the therapeutic equivalent of Zyvox tablets, 600 mg of Pharmacia and Upjohn Company, a subsidiary of Pfizer.
